{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:09:34Z","timestamp":1774076974426,"version":"3.50.1"},"reference-count":41,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,1,15]]},"DOI":"10.2169\/internalmedicine.0027-22","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T22:10:06Z","timestamp":1667340606000},"page":"187-199","source":"Crossref","is-referenced-by-count":14,"title":["Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)"],"prefix":"10.2169","volume":"62","author":[{"given":"Shin","family":"Takayama","sequence":"first","affiliation":[{"name":"Department of Education and Support for Regional Medicine (General and Kampo Medicine), Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Center for Kampo Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kamitsuga General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Irie","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Saitama Medical University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Ogikubo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Katori","sequence":"additional","affiliation":[{"name":"Association of Medical Corporation Riseijinkai Katori Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosaburo","family":"Kainuma","sequence":"additional","affiliation":[{"name":"Department of Japanese Oriental Medicine, Toyama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nogami","sequence":"additional","affiliation":[{"name":"Department of Kampo Medicine, Tokai University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Surgery, Department of Respiratory Medicine, Kesennuma City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Kampo and Nephrology, Saiseikai Kurihashi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Minakawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hirosaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Surgery, Department of Respiratory Medicine, Kesennuma City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Suda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Kampo Medicine, Suda Medical Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Nakada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Shonan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ishige","sequence":"additional","affiliation":[{"name":"Oriental Medicine Research Center, Kitasato University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Maehara","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Ekota Maehara Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Kampo Medicine, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahiko","family":"Nagase","sequence":"additional","affiliation":[{"name":"Kichijyoji Traditional Chinese Medicine Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Kashio","sequence":"additional","affiliation":[{"name":"Kyuden Family Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Komatsu Surgery Internal Medicine Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nojiri","sequence":"additional","affiliation":[{"name":"Shirakawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Shimooki","sequence":"additional","affiliation":[{"name":"Iwate Medical University Hospital, Iwate Medical University Uchimaru Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Japan Traditional Chinese Medical Foundation of Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Arita","sequence":"additional","affiliation":[{"name":"Department of Education and Support for Regional Medicine (General and Kampo Medicine), Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Education and Support for Regional Medicine (General and Kampo Medicine), Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Education and Support for Regional Medicine (General and Kampo Medicine), Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Education and Support for Regional Medicine (General and Kampo Medicine), Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Ohsawa","sequence":"additional","affiliation":[{"name":"Department of Education and Support for Regional Medicine (General and Kampo Medicine), Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Nakae","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamichi","family":"Mitsuma","sequence":"additional","affiliation":[{"name":"Department of Kampo Medicine, Aizu Medical Center, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[{"name":"Center for Kampo Medicine, Keio University School of Medicine, Japan"},{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Education and Support for Regional Medicine (General and Kampo Medicine), Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Nochioka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Wei","family":"Chiu","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Namiki","sequence":"additional","affiliation":[{"name":"Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akito","family":"Hisanaga","sequence":"additional","affiliation":[{"name":"Hospital Bando, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Mitani","sequence":"additional","affiliation":[{"name":"Medical Corporation Mitani Family Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[{"name":"Akashi Clinic Kanda, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. World Health Organization Novel Coronavirus (2019-nCOV) situation report-1 (2019) [Internet]. [cited 2021 Dec 31]. Available from: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200121-sitrep-1-2019-ncov.pdf"},{"key":"2","unstructured":"2. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Internet]. [cited 2021 Dec 31]. Available from: https:\/\/gisanddata.maps.arcgis.com\/apps\/dashboards\/bda7594740fd40299423467b48e9ecf6"},{"key":"3","unstructured":"3. World Health Organization. Coronavirus disease (COVID-19) pandemic [Internet]. [cited 2021 Dec 31]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019"},{"key":"4","unstructured":"4. US Centers for Disease Control and Prevention. Symptoms of COVID-19 [Internet]. [cited 2021 Dec 31]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Wu J, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323: 1239-1242, 2020.","DOI":"10.1001\/jama.2020.2648"},{"key":"6","unstructured":"6. Ministry of Health, Labour and Welfare. Guide to medical treatment for COVID-19 version 6.0 [Internet]. [cited 2021 Dec 31]. Available from: https:\/\/www.mhlw.go.jp\/content\/000851082.pdf"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nabeshima S, Kashiwagi K, Ajisaka K, et al. A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza. J Infect Chemother 18: 534-543, 2012.","DOI":"10.1007\/s10156-012-0378-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Arita R, Ono R, Saito N, et al. Kakkonto, shosaikoto, <i>Platycodon grandiflorum<\/i> root, and gypsum (a Japanese original combination drug known as saikatsugekito): pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID-19. Tradit Kampo Med 7: 115-127, 2020.","DOI":"10.1002\/tkm2.1258"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Takayama S, Kikuchi A, Makino T, Kainuma M, Namiki T, Ito T. Basic pharmacological mechanisms and clinical evidence of the efficacy of hochuekkito against infectious diseases and its potential for use against COVID-19. Tradit Kampo Med 8: 3-21, 2021.","DOI":"10.1002\/tkm2.1264"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Irie Y, Nakae H, Fukui S. Three mild cases of coronavirus disease 2019 treated with saikatsugekito, a Japanese herbal medicine. Tradit Kampo Med 8: 111-114, 2021.","DOI":"10.1002\/tkm2.1261"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Irie Y, Nakae H, Fukui S. Treatment of coronavirus disease 2019 with saikatsugekito: a case series. Tradit Kampo Med 8: 211-220, 2021.","DOI":"10.1002\/tkm2.1290"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Takayama S, Kashima M, Namiki T, et al. Conventional and Kampo medicine in the treatment of mild to moderate COVID-19: a multicenter, retrospective observational study protocol by the integrative management in Japan for epidemic disease (IMJEDI study-observation). Tradit Kampo Med 8: 106-110, 2021.","DOI":"10.1002\/tkm2.1271"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. L\u00f3pez-Medina E, L\u00f3pez P, Hurtado IC, et al. Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19: a randomized clinical trial. JAMA 325: 1426-1435, 2021.","DOI":"10.1001\/jama.2021.3071"},{"key":"14","unstructured":"14. Weinreich DM, Sivapalasingam S, Norton T, et al. REGEN-COV antibody combination and outcomes in outpatients with COVID-19. N Engl J Med 385: e81, 2021."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lenze EJ, Mattar C, Zorumski CF, et al. Fluvoxamine vs. placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA 324: 2292-2300, 2020.","DOI":"10.1001\/jama.2020.22760"},{"key":"16","unstructured":"16. Weinreich DM, Sivapalasingam S, Norton T, et al. REGEN-COV antibody combination and outcomes in outpatients with COVID-19. N Engl J Med 385: e81, 2021."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gupta A, Gonzalez-Rojas Y, Juarez E, et al. Early treatment for COVID-19 with SARS-CoV-2 neutralizing antibody sotrovimab. N Engl J Med 385: 1941-1950, 2021.","DOI":"10.1056\/NEJMoa2107934"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19 - final report. N Engl J Med 383: 1813-1826, 2020.","DOI":"10.1056\/NEJMc2022236"},{"key":"19","unstructured":"19. Kalil AC, Patterson TF, Mehta AK, et al. Baricitinib plus remdesivir for hospitalized adults with COVID-19. N Engl J Med 384: 795-807, 2021."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA 324: 1307-1316, 2020.","DOI":"10.1001\/jama.2020.17021"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Horby P, Lim WS, Emberson JR, et al.; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19. Trial N Engl J Med 384: 693-704, 2021.","DOI":"10.1056\/NEJMoa2021436"},{"key":"22","unstructured":"22. US Centers for Disease Control and Prevention. Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19 [Internet]. [cited 2021 Dec 31]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/underlying-evidence-table.html"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Toots M, Yoon JJ, Cox RM, et al. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci Transl Med 11: eaax5866, 2019.","DOI":"10.1126\/scitranslmed.aax5866"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients. N Engl J Med 386: 509-520, 2022.","DOI":"10.1056\/NEJMoa2116044"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitialized adults with COVID-19. N Engl J Med 386: 1397-1408, 2022.","DOI":"10.1056\/NEJMoa2118542"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Deeks ED. Casirivimab\/imdevimab: first approval. Drugs 81: 2047-2055, 2021.","DOI":"10.1007\/s40265-021-01620-z"},{"key":"27","unstructured":"27. Weinrech DM, Sivapalasingam S, Norton T, et al. REGEN-CoV antibody combination and outcome in outpatients with COVID-19. N Engl J Med 385: e81, 2021."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Copin R, Baum A, Wloga E, et al. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies. Cell 184: 3949-3961.e11, 2021.","DOI":"10.1016\/j.cell.2021.06.002"},{"key":"29","unstructured":"29. Tatham L, Sharp J, Kijak E, et al. Lack of ronapreve (REGN-CoV; casirivimab and imdevimab) virological efficacy against the SARS-CoV-2 omicron variant (B.1.1.529) in K18-hACE2 mice. bioRxiv. Forthcoming."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pinto D, Park YJ, Beltramello M, et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583: 290-295, 2020.","DOI":"10.1038\/s41586-020-2349-y"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Tuccori M, Ferraro S, Convertino I, et al. Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline. MAbs 12: 1854149, 2020.","DOI":"10.1080\/19420862.2020.1854149"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Gupta A, Gonzalez-Rojas Y, Juarez E, et al. Early treatment for COVID-19 with SARS-CoV-2 neutralizing antibody sotrovimab. N Engl J Med 385: 1941-1950, 2021.","DOI":"10.1056\/NEJMoa2107934"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Takayama S, Arita R, Ono R, et al. Treatment of COVID-19-related olfactory disorder promoted by kakkontokasenkyushin&apos;i: a case series. Tohoku J Exp Med 254: 71-80, 2021.","DOI":"10.1620\/tjem.254.71"},{"key":"34","unstructured":"34. Wang R, Yang S, Xie C, et al. Clinical efficacy of Qing Lung detoxification in the treatment of novel coronavirus pneumonia. Pharmacol Clin Chin Mater Med 36, 2020 (in Chinese)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zhang L, Zheng X, Bai X, et al. Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: a national retrospective registry study. Phytomedicine 85: 153531, 2021.","DOI":"10.1016\/j.phymed.2021.153531"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Arai I, Harada Y, Koda H, Tsutani K, Motoo Y. Estimated incidence per population of adverse drug reactions to Kampo medicines from the Japanese adverse drug event report database (JADER). Tradit Kampo Med 7: 1, 2019.","DOI":"10.1002\/tkm2.1234"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Takayama S, Namiki T, Odaguchi H, et al. Prevention and recovery of COVID-19 patients with Kampo medicine: review of case reports and ongoing clinical trials. Front Pharmacol 12: 656246, 2021.","DOI":"10.3389\/fphar.2021.656246"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Namiki T, Takayama S, Arita R, et al. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (integrative management in Japan for epidemic disease by prophylactic study: IMJEDI P1 study). Trials 22: 23, 2021.","DOI":"10.1186\/s13063-020-04939-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Takayama S, Namiki T, Ito T, et al. A multi-center, randomized controlled trial by the integrative management in Japan for epidemic disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial. Trials 21: 827, 2020.","DOI":"10.1186\/s13063-020-04746-9"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Arita R, Yoshino T, Hotta Y, et al. National cost estimation of maoto, a Kampo medicine, compared with oseltamivir for the treatment of influenza in Japan. Tradit Kampo Med 3: 59-62, 2015.","DOI":"10.1002\/tkm2.1027"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Arai I, Kawahara N. Kampo pharmaceutical products in the Japanese health-care system: legal status and quality assurance. Tradit Kampo Med 6: 3-11, 2018.","DOI":"10.1002\/tkm2.1204"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/2\/62_0027-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:08Z","timestamp":1715315468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/2\/62_0027-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0027-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,15]]},"article-number":"0027-22"}}